RHÃN-KLINIKUM AG / Notification of voting rights according to article 26, section 1 WpHG 07.06.2010 14:45 Dissemination of a Voting Rights announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- FIL Holdings Limited, Hildenborough, UK, notified us on 1st June 2010 retroactively pursuant to section 21 (1) WpHG of the following: On 2 January 2009 FIL Holdings Limited exceeded the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt/Saale, Germany. On that date, FIL Holdings Limited held 3.93% of the voting rights in RHÃN-KLINIKUM AG arising from 4,078,458 voting rights. All voting rights in RHÃN-KLINIKUM AG were attributed to FIL Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG in connection with sent. 2 WpHG. In addition, FIL Holdings Limited, Hildenborough, UK, notified us retroactively pursuant to section 21 (1) WpHG of the following: On 30 October 2009 FIL Holdings Limited fell below the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt/Saale, Germany. On that date, FIL Holdings Limited held 2.77% of the voting rights in RHÃN-KLINIKUM AG arising from 3,833,301 voting rights. All voting rights in RHÃN-KLINIKUM AG were attributed to FIL Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG in connection with sent. 2 WpHG. Correction to voting rights filing according to sec. 26 para. 1 WpHG dated 4th November 2009 FIL Limited, Hamilton, Bermuda, notified us on 1st June 2010 a correction to their filing dated 2nd November 2009 pursuant to section 21 (1) WpHG of the following: On 30 October 2009 FIL Limited fell below the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt/Saale, Germany. On that date, FIL Limited held 2.80% of the voting rights in RHÃN-KLINIKUM AG arising from 3,863,833 voting rights. Of this amount, 0.02% (30,532 voting rights) is to be attributed pursuant sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG and 2.77% (3,833,301 voting rights) is to be attributed pursuant sec. 22 para. 1 sent. 1 no. 6 WpHG. In addition, FIL Investment Management Limited, Hildenborough, UK, notified us a correction to their filing dated 2nd November 2009 pursuant to section 21 (1) WpHG of the following: On 30 October 2009 FIL Investment Management Limited fell below the threshold of 3% of the voting rights in RHÃN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt/Saale, Germany. On that date, FIL Investment Management Limited held 2.80% of the voting rights in RHÃN-KLINIKUM AG arising from 3,863,833 voting rights. All voting rights in RHÃN-KLINIKUM AG were attributed to FIL Investment Management Limited pursuant to section 22 (1) sent. 1 no. 6 in connection with sent. 2 WpHG. Bad Neustadt a.d. Saale, 7 June 2010 The Board of Management ___________________________________________________________________ Esther Walter Leiterin Presse- und Ãffentlichkeitsarbeit Konzern RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: 09771/ 65 - 1322 Telefax: 09771/ 65 - 1820 Boris Tramm Head of Investor Relations RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: 09771/ 65 - 1318 Telefax: 09771/ 991736 07.06.2010 14:45 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|] --------------------------------------------------------------------------- Language: English Company: RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Deutschland Internet: www.rhoen-klinikum-ag.com End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG